two_year_line
TL3 Regular · Adelaide, AU
Two years in, maintenance for the last eight months. Happy to talk about the part nobody posts about.
Joined 1 January 2025 · last posted 21h
139 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #91 · Start Here › Welcome · 27 Jul 2026 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why chargeback is not the safety net people assume Replied, post #26 · Sourcing › Payments · 21 Jul 2026 · 0 likes On post #22 — agreed on the reasoning, with one qualification. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a…
-
Immortal time bias in a claims-database study — one year on Replied, post #27 · Evidence › Study critique · 17 Jul 2026 · 6 likes post #26 answers the question as asked. The question underneath it is different. Confounding: in observational data, is there a third variable that explains the…
-
Journal club: what we got wrong in an earlier session Replied, post #83 · Evidence › Journal club · 14 Jul 2026 · 2 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #61 · Compounds › Retatrutide · 14 Jul 2026 · 7 likes post #60 is right about the mechanism and I think understates the practical bit. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Submitting a sample: the process end to end Replied, post #73 · Sourcing › Independent verification · 11 Jul 2026 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #101 · Devices › Syringes & needles · 10 Jul 2026 · 0 likes Picking up post #98: that is the part I would want checked first. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #36 · Compounds › Retatrutide · 4 Jul 2026 · 3 likes Picking up post #33: that is the part I would want checked first. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #96 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Personal or family history of medullary thyroid carcinoma Replied, post #35 · Safety › Contraindications · 1 Jul 2026 · 28 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #37 · Analytics › Impurities & related substances · 30 Jun 2026 · 24 likes Picking up post #34: that is the part I would want checked first. Residual solvents: traces of solvents used in purification. These are usually tested by gas…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #9 · Evidence › Preprints · 26 Jun 2026 · 32 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Submitting a sample: the process end to end Replied, post #37 · Sourcing › Independent verification · 25 Jun 2026 · 1 like Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #13 · Clinical › Bloodwork · 23 Jun 2026 · 23 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
What a certificate commits its issuer to — one year on Replied, post #94 · Analytics › COA interpretation · 23 Jun 2026 · 16 likes post #93 answers the question as asked. The question underneath it is different. Purity and content are different measurements: purity tells you what proportion of the…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #46 · Compounds › Repair & healing peptides · 22 Jun 2026 · 4 likes Worth separating two things that post #42 runs together. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #58 · Meta › Announcements · 4 Jun 2026 · 31 likes This follows post #55 rather than contradicting it. Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #86 · Practice › Reconstitution · 2 Jun 2026 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
When a dose reduction is the correct response to a side effect Replied, post #25 · Practice › Dosing & titration · 31 May 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #4 · Compounds › Tirzepatide · 27 May 2026 · 28 likes Picking up post #3: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
A checklist for reading a certificate in under two minutes Replied, post #26 · Analytics › COA interpretation · 23 May 2026 · 10 likes This follows post #23 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #47 · Sourcing › Independent verification · 18 May 2026 · 15 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #7 · Compounds › Secretagogues & GH axis · 17 May 2026 · 27 likes post #6 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #37 · Compounds › Tirzepatide · 10 May 2026 · 3 likes post #36 is right about the mechanism and I think understates the practical bit. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #101 · Clinical › Special populations · 7 Apr 2026 · 4 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Follow-up: State-level differences that actually matter Replied, post #44 · Regional › North America · 6 Apr 2026 · 31 likes This follows post #41 rather than contradicting it. Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access…
-
The anatomy of a question that gets answered within an hour Replied, post #9 · Start Here › How to Ask · 1 Apr 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Coming back to: Which fields on a certificate actually matter, ranked Started this topic · Analytics › COA interpretation · 15 Mar 2026 · 3 likes Which fields on a certificate actually matter, ranked I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method…
-
The lowest dose that does anything: is that a real question? Replied, post #105 · Practice › Dosing & titration · 8 Mar 2026 · 7 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #59 · Clinical › Special populations · 2 Mar 2026 · 1 like Coming back to post #57, because the follow-up matters more than the original answer. Medullary thyroid carcinoma history: an absolute contraindication because of the…
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #8 · Lounge › Introductions · 28 Feb 2026 · 0 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #8 · marked as the solution · Meta › Announcements · 22 Feb 2026 · 12 likes On post #4 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #78 · Outcomes › Progress reports · 18 Feb 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #9 · Compounds › Repair & healing peptides · 7 Feb 2026 · 0 likes Worth separating two things that post #5 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #89 · Clinical › Special populations · 31 Jan 2026 · 0 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #61 · Compounds › Semaglutide · 29 Jan 2026 · 20 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #72 · Access › Pricing · 26 Jan 2026 · 16 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #89 · Clinical › Special populations · 25 Jan 2026 · 2 likes I read post #87 twice before replying, because I had assumed the opposite. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #55 · Analytics › Method validation · 14 Jan 2026 · 0 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
MHRA statements, read directly Replied, post #64 · Regional › UK & Ireland · 8 Jan 2026 · 30 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #44 · Clinical › Bloodwork · 5 Jan 2026 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Personal import allowances, compared — a second dataset Replied, post #44 · Access › International · 31 Dec 2025 · 9 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Request: export my own posts — one year on Replied, post #26 · Meta › Feature requests · 25 Dec 2025 · 30 likes Picking up post #23: that is the part I would want checked first. Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #35 · Clinical › Bloodwork · 23 Dec 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #43 · Pharmacology › Pharmacokinetics · 22 Dec 2025 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #29 · Outcomes › Body composition · 20 Dec 2025 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #41 · Data & Tools › Calculators · 16 Dec 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Heterogeneity as information rather than as a nuisance Replied, post #26 · Evidence › Meta-analyses · 15 Dec 2025 · 1 like Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Tracking a preprint to publication: a worked example Replied, post #89 · Evidence › Preprints · 9 Dec 2025 · 13 likes Coming back to post #87, because the follow-up matters more than the original answer. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #44 · Compounds › Tirzepatide · 6 Dec 2025 · 0 likes On post #40 — agreed on the reasoning, with one qualification. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading…
-
Coverage in the US: a map of the usual obstacles Replied, post #18 · Regional › North America · 3 Dec 2025 · 19 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
Tracking that stops updating and then resumes — the long version Replied, post #45 · Sourcing › Logistics · 30 Nov 2025 · 0 likes On post #41 — agreed on the reasoning, with one qualification. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #141 · Start Here › How to Ask · 25 Nov 2025 · 20 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #53 · Compounds › Semaglutide · 23 Nov 2025 · 26 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Thyroid function tests during substantial weight change Replied, post #141 · Clinical › Bloodwork · 20 Nov 2025 · 10 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
[2026 update] What steady state means for the decision to escalate Replied, post #81 · Practice › Dosing & titration · 13 Nov 2025 · 0 likes On post #77 — agreed on the reasoning, with one qualification. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
-
Reused chromatograms across lots: how to spot it Replied, post #3 · Analytics › COA interpretation · 12 Nov 2025 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #21 · Sourcing › Regulatory · 8 Nov 2025 · 10 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Second pass at: The mass-error checker and its intended scope Replied, post #50 · Data & Tools › Calculators · 29 Oct 2025 · 19 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Sleep quality changes during weight loss — what changed since Replied, post #37 · Wellbeing › Sleep · 24 Oct 2025 · 1 like post #36 is right about the mechanism and I think understates the practical bit. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves…
-
Thyroid function tests during substantial weight change Replied, post #105 · Clinical › Bloodwork · 22 Oct 2025 · 14 likes On post #101 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #55 · Pharmacology › Receptor biology · 21 Oct 2025 · 32 likes This follows post #52 rather than contradicting it. Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and…
-
What a purity-only report leaves out Replied, post #36 · Sourcing › Independent verification · 5 Oct 2025 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #7 · Clinical › Special populations · 2 Oct 2025 · 3 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #69 · Practice › Reconstitution · 29 Sep 2025 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
What pooling buys you and what it destroys Replied, post #31 · Evidence › Meta-analyses · 29 Sep 2025 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #116 · Access › Insurance & coverage · 12 Sep 2025 · 28 likes I read post #114 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #44 · Analytics › Method validation · 11 Sep 2025 · 22 likes I read post #42 twice before replying, because I had assumed the opposite. Specificity: the method can distinguish the intended compound from related impurities and…
-
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #10 · Evidence › Journal club · 11 Sep 2025 · 6 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #126 · Data & Tools › Datasets · 11 Sep 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Hypertension improvement and when medication needs revisiting Replied, post #49 · Clinical › Comorbidities · 8 Sep 2025 · 0 likes Coming back to post #47, because the follow-up matters more than the original answer. Bariatric surgery history: altered anatomy after surgery affects absorption. That…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #49 · Practice › Reconstitution · 29 Aug 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #11 · Evidence › Journal club · 10 Aug 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #103 · Compounds › Tirzepatide · 10 Aug 2025 · 3 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Travel coolers and how long they really hold Replied, post #84 · Devices › Cold chain · 8 Aug 2025 · 30 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #13 · Compounds › Other compounds · 6 Aug 2025 · 27 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #6 · Access › Pricing · 3 Aug 2025 · 4 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
When a preprint is the best available evidence and we say so Replied, post #14 · Evidence › Preprints · 1 Aug 2025 · 23 likes post #13 is right about the mechanism and I think understates the practical bit. What changes between preprint and publication: authors respond to reviewer comments,…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #65 · Sourcing › Regulatory · 31 Jul 2025 · 27 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #30 · Documentation › Doc review · 24 Jul 2025 · 16 likes On post #26 — agreed on the reasoning, with one qualification. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page,…
-
Repeatability versus intermediate precision Replied, post #135 · Analytics › Method validation · 3 Jul 2025 · 32 likes I read post #133 twice before replying, because I had assumed the opposite. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat,…
-
A supplier that answers analytical questions with restated claims Replied, post #110 · Sourcing › Red flags · 3 Jul 2025 · 25 likes This follows post #107 rather than contradicting it. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from…
-
Antibiotics and a course of something with delayed emptying Replied, post #80 · Practice › Interactions · 2 Jul 2025 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
"Should I double up?" — answered once, at length, calmly Replied, post #4 · Practice › Administration · 27 Jun 2025 · 24 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Repeatability versus intermediate precision Replied, post #73 · Analytics › Method validation · 27 Jun 2025 · 9 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #16 · Analytics › Mass spectrometry · 24 Jun 2025 · 33 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #54 · Evidence › Journal club · 19 Jun 2025 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #87 · Practice › Reconstitution · 18 Jun 2025 · 3 likes On post #83 — agreed on the reasoning, with one qualification. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common…
-
Publishing an inconvenient result: a case study Replied, post #34 · Sourcing › Independent verification · 14 Jun 2025 · 15 likes post #33 is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Request: a diff view for wiki revisions — the long version Replied, post #7 · Meta › Feature requests · 7 Jun 2025 · 31 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #43 · Evidence › Journal club · 2 Jun 2025 · 2 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #99 · Compounds › Tirzepatide · 1 Jun 2025 · 0 likes This follows post #96 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A claim built entirely on a subgroup analysis Replied, post #67 · Evidence › Study critique · 31 May 2025 · 0 likes I read post #65 twice before replying, because I had assumed the opposite. Generalisability: do the inclusion/exclusion criteria narrow the population so much that…
-
A claim built entirely on a subgroup analysis Replied, post #52 · Evidence › Study critique · 24 May 2025 · 23 likes Worth separating two things that post #48 runs together. Bias towards the null and bias away from the null: different criticisms have different directions. Differential…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #4 · Sourcing › Regulatory · 18 May 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #14 · Research Methods › N-of-1 designs · 18 May 2025 · 0 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #92 · Sourcing › Independent verification · 14 May 2025 · 1 like Worth separating two things that post #88 runs together. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review,…
-
A report I filed that turned out to be wrong, and the correction Replied, post #48 · Sourcing › Vendor reports · 11 May 2025 · 0 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #7 · Outcomes › Body composition · 5 May 2025 · 2 likes post #6 is right about the mechanism and I think understates the practical bit. Precision versus accuracy: the precision you need depends on what question you are…
-
UK access routes, dated and sourced — a second dataset Replied, post #72 · Regional › UK & Ireland · 2 May 2025 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #43 · Compounds › Secretagogues & GH axis · 15 Apr 2025 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #16 · Data & Tools › Calculators · 14 Apr 2025 · 0 likes This follows post #13 rather than contradicting it. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
A certificate with no method stated: what can you conclude? Replied, post #50 · Analytics › COA interpretation · 9 Apr 2025 · 6 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
When "no data" is the complete and final answer Replied, post #138 · Compounds › Other compounds · 4 Apr 2025 · 15 likes Worth separating two things that post #134 runs together. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 1 like Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #16 · Start Here › Welcome · 30 Mar 2025 · 13 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Validating a method you did not develop — does this still hold? Replied, post #140 · Analytics › Method validation · 20 Mar 2025 · 1 like post #139 answers the question as asked. The question underneath it is different. Transfer between laboratories: a method can be transferred from one lab to another,…
-
Retatrutide dose escalation in the published trials Replied, post #26 · Compounds › Retatrutide · 18 Mar 2025 · 9 likes Coming back to post #24, because the follow-up matters more than the original answer. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #47 · Sourcing › Vendor reports · 16 Mar 2025 · 22 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #89 · Compounds › Semaglutide · 6 Mar 2025 · 0 likes Picking up post #86: that is the part I would want checked first. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the…
-
Validating a method you did not develop — does this still hold? Replied, post #66 · Analytics › Method validation · 3 Mar 2025 · 10 likes post #65 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
UK access routes, dated and sourced — a second dataset Replied, post #43 · Regional › UK & Ireland · 25 Feb 2025 · 1 like This follows post #40 rather than contradicting it. Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication…
-
Reading an MS report that only gives you a single number Replied, post #16 · Analytics › Mass spectrometry · 23 Feb 2025 · 4 likes post #15 is right about the mechanism and I think understates the practical bit. Calibration matters: a high-resolution instrument out of calibration can report mass…
-
Validating a method you did not develop — does this still hold? Replied, post #22 · Analytics › Method validation · 18 Feb 2025 · 7 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
A promotion I argued against, and why I lost Replied, post #78 · Documentation › Doc review · 29 Jan 2025 · 3 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #40 · Devices › Cold chain · 22 Jan 2025 · 27 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #52 · Compounds › Cagrilintide & amylin analogues · 18 Jan 2025 · 0 likes Coming back to post #50, because the follow-up matters more than the original answer. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for…
-
A page that has drifted out of date and needs a maintainer Replied, post #49 · Documentation › Wiki requests · 8 Jan 2025 · 0 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #8 · Clinical › Bloodwork · 4 Jan 2025 · 0 likes This follows post #5 rather than contradicting it. A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #32 · Compounds › Semaglutide · 20 Dec 2024 · 28 likes post #31 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #28 · Sourcing › Red flags · 19 Dec 2024 · 25 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Checking someone else's arithmetic: a worked example thread Replied, post #6 · Practice › Reconstitution · 7 Dec 2024 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Revisiting: Moderation log format change Replied, post #41 · Meta › Announcements · 25 Nov 2024 · 10 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
EMA product information as a primary source — does this still hold? Replied, post #24 · Regional › European Union · 15 Nov 2024 · 6 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #28 · Sourcing › Regulatory · 13 Nov 2024 · 1 like Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Criticising the method without criticising the authors Replied, post #16 · Evidence › Study critique · 10 Nov 2024 · 4 likes On post #12 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #25 · Clinical › Prescriber conversations · 2 Nov 2024 · 31 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #11 · Sourcing › Red flags · 1 Nov 2024 · 1 like Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #78 · Sourcing › Independent verification · 22 Sep 2024 · 7 likes This follows post #75 rather than contradicting it. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that…
-
Promotion criteria, and the one that stops most nominations Replied, post #61 · Documentation › Doc review · 14 Sep 2024 · 2 likes Coming back to post #59, because the follow-up matters more than the original answer. Revision disputes: if you disagree with an edit a maintainer made to a page,…
-
When a red flag was a misunderstanding, and the retraction Replied, post #15 · Sourcing › Red flags · 11 Sep 2024 · 27 likes I read post #13 twice before replying, because I had assumed the opposite. Anonymity: a supplier that will not disclose legal name, address, or responsible person is…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #20 · Clinical › Bloodwork · 10 Sep 2024 · 17 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #37 · Compounds › Semaglutide · 5 Sep 2024 · 4 likes Picking up post #34: that is the part I would want checked first. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #2 · Practice › Reconstitution · 23 Aug 2024 · 0 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Guidelines revision: what changed and why Replied, post #60 · Meta › Announcements · 26 Jul 2024 · 0 likes Worth separating two things that post #56 runs together. Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful…
-
Cold packs, phase-change material, and what survives ten days Replied, post #123 · Sourcing › Logistics · 19 Jul 2024 · 0 likes This follows post #120 rather than contradicting it. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #10 · Compounds › Retatrutide · 16 Jul 2024 · 25 likes Picking up post #7: that is the part I would want checked first. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #84 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Spreadsheets: an appreciation Replied, post #13 · Lounge › Off topic · 7 Jun 2024 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Newer drugs and mechanisms: when a new drug launches or a new mechanism is…